Zoster Vaccine Live (Oka/Merck)

被引：0
|
作者：
Dean M. Robinson
Caroline M. Perry
机构：
[1] Adis International Limited,
来源：
Drugs & Aging | 2006年 / 23卷
关键词：
Herpes Zoster; Varicella Zoster Virus; Postherpetic Neuralgia; Famciclovir; Varicella Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
▴ A subcutaneously administered, live, high-titre (18 700–60 000 plaque-forming units per dose) varicella zoster virus (VZV) vaccine (zoster vaccine) of the Oka/Merck strain has been evaluated for the prevention of herpes zoster and the reduction of zoster-associated pain in adults aged ≥60 years.
引用
收藏
页码：525 / 531
页数：6
相关论文
共 50 条
  • [1] Zoster vaccine live (Oka/Merck)
    Cunningham, Anthony L.
    DRUGS & AGING, 2006, 23 (06) : 532 - 532
  • [2] Zoster vaccine live (Oka/Merck): profile report
    Drugs & Therapy Perspectives, 2007, 23 (2) : 5 - 6
  • [3] Zoster Vaccine Live (Oka/Merck)A Viewpoint by Robert Johnson
    Robert Johnson
    Drugs & Aging, 2006, 23 (6) : 532 - 533
  • [4] Zoster Vaccine Live (Oka/Merck)A Viewpoint by Anthony L. Cunningham
    Anthony L. Cunningham
    Drugs & Aging, 2006, 23 (6) : 532 - 532
  • [5] Exacerbation of Herpes Zoster Ophthalmicus (HZO) Following Zoster Vaccine, Live, Attenuated [Oka/Merck]: A Case Series
    Taylor, Elaine
    Legare, C.
    Duc Vu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 441 - 441
  • [6] SAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF LIVE ATTENUATED OKA/MERCK VARICELLA VACCINE (VARIVAX)
    ROTHSTEIN, EP
    BERNSTEIN, HH
    SCHILLER, RP
    GIRONE, JAC
    HIPP, TJ
    SOUDER, RL
    KENNEDY, TI
    FACCENDA, DR
    MARCIANO, JA
    LONG, SS
    PEDIATRIC RESEARCH, 1994, 35 (04) : A194 - A194
  • [7] LIVE OKA MERCK VARICELLA VACCINE IN HEALTHY-CHILDREN - FURTHER CLINICAL AND LABORATORY ASSESSMENT
    WEIBEL, RE
    KUTER, BJ
    NEFF, BJ
    ROTHENBERGER, CA
    FITZGERALD, AJ
    CONNOR, KA
    MORTON, D
    MCLEAN, AA
    SCOLNICK, EM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (17): : 2435 - 2439
  • [8] Spontaneous reports of breakthrough varicella in individuals vaccinated with VARIVAX ™ [Varicella Virus vaccine live (Oka/Merck)]
    Galea, S.
    Sweet, A.
    Sharrar, R.
    Beninger, P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S78 - S79
  • [9] Safety profile of live varicella virus vaccine (Oka/Merck): Five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP)
    Goulleret, Nicolas
    Mauvisseau, Elodie
    Essevaz-Roulet, Melanie
    Quinlivan, Mark
    Breuer, Judy
    VACCINE, 2010, 28 (36) : 5878 - 5882
  • [10] Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax(R)) in children and adults
    Krah, DL
    Cho, IS
    Schofield, T
    Ellis, RW
    VACCINE, 1997, 15 (01) : 61 - 64
12345